When you have advanced prostate cancer: What living with the disease looks like
When You Have Advanced Prostate: Understanding Your Journey
Earthguardiansonline.com – When you have advanced prostate cancer, the diagnosis can feel overwhelming, but modern medicine has transformed what living with this condition truly means. Dr. Jamin Brahmbhatt, a robotic surgeon and urologist at Orlando Health who also serves as an assistant professor at the University of Central Florida’s medical school, sees this firsthand. He explains that when patients receive their diagnosis, one question consistently rises to the surface. He remembers hearing it repeatedly from men just like him:
“How long do I have to live?”
For those with early-stage or low-grade prostate cancer, Brahmbhatt provides substantial reassurance. He notes that the outlook is generally positive, with patients experiencing a five-year relative survival rate surpassing 99% once treatment commences. Put simply, most men will not die from low-grade prostate cancer. Yet, the story changes considerably when the cancer spreads beyond the prostate into bones and other organs. In these situations, offering a straightforward answer proves much more challenging.
A President’s Public Health Update
Treatment strategies for advanced cases have evolved dramatically throughout the past decade. Breakthroughs in medications, enhanced imaging capabilities, and earlier combination therapies are helping men live longer, fuller lives. This progress gained national attention when former President Joe Biden provided a personal update in a video posted on July 15. He communicated that his ongoing treatments are moving forward well.
Medical officials confirmed his diagnosis in May 2025, when Biden disclosed he was fighting an aggressive form of prostate cancer that had spread to his bones. Since that revelation, reports show he has continued hormone therapy, completed a course of radiation treatment, and remained active in public life. His situation has generated fresh conversation about screening recommendations and available treatment pathways for prostate cancer patients nationwide.
Context Matters in Survival Statistics
Now, more than twelve months following his initial announcement, Biden’s experience offers patients a meaningful reference point for understanding advances in advanced prostate cancer care. Numerous individuals who have not yet spoken with their doctors search online for survival data. Brahmbhatt warns, however, that every statistic encountered on the internet contains important context. The American Cancer Society reports that the five-year relative survival rate exceeds 99% for cancers found within or near the prostate. Meanwhile, that figure drops to approximately 38% when the disease has metastasized to distant areas of the body.
Importantly, this lower percentage stems from information gathered from large groups of men who received treatment several years ago. It does not fully reflect the impact of current medical approaches, nor does it account for a patient’s age, overall wellness, or personal response to therapy. While survival numbers illustrate broader population patterns, they cannot predict individual results. Therefore, when you have advanced prostate cancer, your personal journey may look quite different from what historical data suggests.
Beyond survival rates, patients must also consider quality of life. Modern treatments aim not only to extend lifespan but to maintain daily functioning and comfort. Many men continue working, traveling, and enjoying time with family while managing their condition. Brahmbhatt emphasizes that treatment plans are increasingly personalized, taking into account both the cancer’s characteristics and the patient’s lifestyle preferences.
Emotional support remains equally vital. When you have advanced prostate cancer, connecting with others who understand your experience can make a meaningful difference. Support groups, counseling services, and online communities provide spaces for sharing concerns and celebrating small victories. Healthcare teams are also incorporating mental health resources more frequently into comprehensive care plans.
Looking ahead, research continues to uncover new possibilities. Clinical trials exploring immunotherapy, targeted drug delivery, and genetic markers offer hope for even better outcomes. As science progresses, the definition of advanced prostate cancer keeps expanding to include more treatment options and longer survival timelines. For men navigating this diagnosis today, there is genuine reason for optimism about what the future holds.
